NCT00124111View on ClinicalTrials.gov

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Breast Cancer
Interventions
DRUG

pegfilgrastim

DRUG

cyclophosphamide

DRUG

methotrexate

DRUG

5-fluorouracil

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00124111 - A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | Biotech Hunter | Biotech Hunter